Stock Scorecard
Stock Summary for AVITA Medical Inc (RCEL) - $5.70 as of 7/14/2025 2:01:46 PM EST
Total Score
6 out of 30
Safety Score
20 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for RCEL
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for RCEL
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for RCEL
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for RCEL
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for RCEL (20 out of 100)
| Stock Price Rating (Max of 10) | 4 |
| Historical Stock Price Rating (Max of 10) | 5 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 1 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 4 |
| Analyst Strong Buy Ratings (Max of 5) | 0 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 5 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | 0 |
Latest News for for RCEL
Financial Details for RCEL
Company Overview |
|
|---|---|
| Ticker | RCEL |
| Company Name | AVITA Medical Inc |
| Country | USA |
| Description | AVITA Medical Inc. is a commercial stage regenerative tissue company in the United States, Australia, and the United Kingdom. The company is headquartered in Valencia, California. |
| Sector Name | LIFE SCIENCES |
| Industry Name | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Most Recent Quarter | 3/31/2025 |
| Next Earnings Date | 8/7/2025 |
Stock Price History |
|
| Last Day Price | 5.70 |
| Price 4 Years Ago | 11.98 |
| Last Day Price Updated | 7/14/2025 2:01:46 PM EST |
| Last Day Volume | 266,671 |
| Average Daily Volume | 332,506 |
| 52-Week High | 14.16 |
| 52-Week Low | 4.71 |
| Last Price to 52 Week Low | 21.02% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 39.01 |
| Sector PE | 41.70 |
| 5-Year Average PE | -7.81 |
| Free Cash Flow Ratio | 10.18 |
| Industry Free Cash Flow Ratio | 37.30 |
| Sector Free Cash Flow Ratio | 33.25 |
| Current Ratio Most Recent Quarter | 2.09 |
| Total Cash Per Share | 0.56 |
| Book Value Per Share Most Recent Quarter | -0.17 |
| Price to Book Ratio | 11.77 |
| Industry Price to Book Ratio | 5.22 |
| Sector Price to Book Ratio | 31.09 |
| Price to Sales Ratio Twelve Trailing Months | 2.31 |
| Industry Price to Sales Ratio Twelve Trailing Months | 5.95 |
| Sector Price to Sales Ratio Twelve Trailing Months | 35.30 |
| Analyst Buy Ratings | 4 |
| Analyst Strong Buy Ratings | 0 |
Share Statistics |
|
| Total Shares Outstanding | 26,434,700 |
| Market Capitalization | 150,677,790 |
| Institutional Ownership | 26.86% |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | -74.80% |
| Reported EPS 12 Trailing Months | -2.19 |
| Reported EPS Past Year | -0.83 |
| Reported EPS Prior Year | -2.65 |
| Net Income Twelve Trailing Months | -57,046,000 |
| Net Income Past Year | -61,845,000 |
| Net Income Prior Year | -35,381,000 |
| Quarterly Revenue Growth YOY | 66.70% |
| 5-Year Revenue Growth | 64.12% |
| Operating Margin Twelve Trailing Months | -63.90% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 14,870,000 |
| Total Cash Past Year | 14,050,000 |
| Total Cash Prior Year | 22,118,000 |
| Net Cash Position Most Recent Quarter | -26,594,000 |
| Net Cash Position Past Year | -28,195,000 |
| Long Term Debt Past Year | 42,245,000 |
| Long Term Debt Prior Year | 39,812,000 |
| Total Debt Most Recent Quarter | 41,464,000 |
| Equity to Debt Ratio Past Year | 0.10 |
| Equity to Debt Ratio Most Recent Quarter | -0.12 |
| Total Stockholder Equity Past Year | 4,499,000 |
| Total Stockholder Equity Prior Year | 49,056,000 |
| Total Stockholder Equity Most Recent Quarter | -4,571,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -46,721,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -1.77 |
| Free Cash Flow Past Year | -58,272,000 |
| Free Cash Flow Prior Year | -39,458,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | -0.36 |
| MACD Signal | -0.46 |
| 20-Day Bollinger Lower Band | 4.08 |
| 20-Day Bollinger Middle Band | 7.32 |
| 20-Day Bollinger Upper Band | 10.57 |
| Beta | 1.55 |
| RSI | 43.03 |
| 50-Day SMA | 9.38 |
| 150-Day SMA | 10.97 |
| 200-Day SMA | 10.77 |
System |
|
| Modified | 7/11/2025 9:12:08 AM EST |